We recently discovered novel pseudotripeptides, ketomemicins, which possess a Cterminal pseudodipeptide connected with a carbonyl methylene instead of an amide bond, through heterologous expression of gene clusters identified in actinobacteria. The carbonyl methylene structure is a stable isostere of the amide bond and its biological significance has been shown in several natural and synthetic products. Despite the biological importance of these compounds, little is known about how the carbonyl methylene structure is biosynthesized. In this article, we fully characterized the biosynthetic machinery of the pseudodipeptide. An aldolase, dehydratase, PLP-dependent glycine-C-acetyltransferase, and dehydrogenase were involved in the formation of the pseudodipeptide with malonyl-CoA and phenylpyruvate as starter substrates.
Peptides are indispensable for all living organisms and play many important roles in biological processes. Because peptides are labile in biological systems, peptidomimetic compounds that overcome this problem have attracted attention for their potential as enzyme inhibitors or receptor ligands. In drug design, a widely used strategy is to replace the peptide backbone with nonhydrolyzable isosteres such as esters, alkenes, and carbonylmethylenes. [1] Nature employs a similar strategy although such molecules are not widely distributed. The largest group of pseudopeptide natural products is depsipeptides, where the isosteric replacement is an ester bond. Besides depsipeptides, two types of carbonylmethylene-containing pseudopeptides, arphamenines (1, 2) and ketomemicins (3, 4), are known. Arphamenines A and B are pseudodipeptides isolated from Chromobacterium violaceum BMG361-CF4 and show potent activity as aminopeptidase B inhibitors. [2] Ketomemicins are pseudotripeptides that we recently discovered through heterologous expression of gene clusters identified in actinobacteria from three genera, Micromonospora sp. ATCC 39149, Streptomyces mobaraensis NBRC 13819,
and Salinispora tropica CNB-440 (Figure 1 ). [3] Ketomemicins contain C-terminal pseudodipeptides closely related to arphamenines. Although arphamenines and ketomemicins are the only known examples of naturally occurring pseudopeptides with a carbonylmethylene moiety, synthetic peptide isosteres with a carbonylmethylene structure have been developed as protease inhibitors in a variety of synthetic studies such as rupintrivir (AG7088).
[4] Despite the biological importance of these molecules, little is known about how the carbonylmethylene structure is biosynthesized. Taking advantage of the genetic information on ketomemicin biosynthesis, in this study, we performed the in vitro functional characterization of the biosynthetic pathway of the pseudopeptide moiety of ketomemicins B3 (3) and B4 (4).
ktmA ktmB ktmC ktmD ktmE ktmF There are six genes in each of the three clusters and we have assigned each gene a systematic name. The names, their corresponding locus tags, and proposed functions are summarized in Table 1 . We reported that KtmD, a homolog of peptide ligase PGM1 involved in pheganomycin biosynthesis [5] , is the (pseudo)dipeptide ligase responsible for the amide bond formation between the amidino-amino acid and pseudodipeptide in the final step of ketomemicin biosynthesis. [3] The N-terminal substrates of KtmD are generated by KtmE catalyzing an amidinotransfer reaction. [6] These results suggested that the remaining four genes in the ktm cluster-ktmA, ktmB, ktmC, and ktmF-are involved in the biosynthesis of the pseudodipeptide. The amino acid sequence of KtmA showed significant homology to CitE family enzymes.
The original CitE is the β-subunit of the bacterial ATP-independent citrate lyase and consists of α, β, and γ subunits. [7] Using an acyl carrier protein (ACP, γ subunit) as a scaffold, CitE catalyzes a retro-aldol reaction from citryl-ACP to oxaloacetate and acetyl-ACP ( Figure S1 ).
Other CitE-like enzymes include malyl-CoA lyases [8] , malyl-CoA thioesterases [9] , and malate synthases [10] , which utilize acyl-CoA thioesters as substrates. The translated gene product of ktmB showed homology to various PLP-dependent amino acid Cα-acyltransferases ( Figure   S2 ). [11] This family of enzymes catalyzes C-C bond formation between the Cα of an amino acid and the carbonyl carbon of an acyl-CoA thioester, followed by decarboxylation to generate an α-oxoamine structure. KtmC and KtmF are homologs of dehydratases and NAD(P)H-dependent reductase, respectively.
On the basis of homology analysis, we propose a possible biosynthetic pathway to generate the pseudodipeptide structure ( Figure 2 ). This pathway includes 1) an aldol reaction between acetyl-CoA and phenylpyruvate catalyzed by KtmA, 2) a dehydration (KtmC) and an enoyl reduction (KtmF) to reduce the -OH group generated by the aldolase reaction, and 3) a C-C bond formation between phenylalanine and acyl-CoA to produce an α-oxoamine structure by KtmB. However, three possible pathways can be envisioned depending on the timing of the KtmB reaction (Pathways A-C). To confirm the proposed pathways, the four genes in the ktm cluster of S. mobaraensis were individually cloned into pET28b (+) expression vectors. Each of them was heterologously expressed in Escherichia coli BL21 (DE3) and purified as an N-terminal His-tagged protein by affinity chromatography using Ni-NTA resin to near homogeneity. SDS-PAGE of the purified proteins clearly showed production of the recombinant proteins ( Figure S3 ).
To examine the aldolase reaction, the purified KtmA was incubated with acetyl-CoA (5) and phenylpyruvate (6) in the presence of MgCl 2 because other CitE-like family enzymes requires a divalent metal. However, no products were formed ( Figure 3 , trace A). Then, malonylCoA (13) was used as a substrate instead of acetyl-CoA because the malonyl-moiety is known to serve as a surrogate of acetate, exemplified by ketosynthases in fatty acid synthases that catalyze a decarboxylation-induced Claisen condensation reaction, and reactions of aldolases driven by decarboxylation are also known. [12] KtmA was incubated with phenylpyruvate (6) and malonylCoA (13) and the reaction mixture was subjected to HPLC analysis. A new product peak was observed in the reaction mixture ( Figure 3 , traces B and C). The molecular mass of this new product was consistent with that of the proposed benzylmalyl-CoA (7) ion for its activity ( Figure S4 ). We also determined the kinetic parameters of the KtmA reaction.
As shown in Figures S5 and S6 , the KtmA reaction followed Michaelis-Menten kinetics and the kinetic parameters (Table 2) were determined by fitting the data points to the Hanes-Woolf plot equation. However, it is worthwhile noting that the K M value for the malonyl-CoA of KtmA is high compared to those of other malonyl-CoA specific enzymes from secondary metabolite biosynthesis. We thus cannot completely rule out the possibility that KtmA generates benzylmalyl-ACP from malonyl-ACP and phenylpyruvate (6) in a similar manner with citrate lyase reaction. with the appearance of two new peaks that coeluted with diastereomers of synthetic pseudophenylalanyl-phenylalanine (12) [3] . NADH also functioned as a hydride source. Taken together, our results unequivocally established the formation of the pseudodipeptide in ketomemicin biosynthesis ( Figure 6 ). This pathway is consistent with early feeding experiments using 13 Clabeled acetate in the biosynthesis of arphamenines, where the C-3 and C-4 carbons are derived from C-2 and C-1 of acetate, respectively.
[13] 
TOC Summary
The biosynthetic pathway of the carbonylmethylene-containing pseudopeptide in ketomemicins was fully elucidated in vitro. The pathway involves two unique C-C bond formations. KtmA catalyzes an aldol reaction concomitant with decarboxylation starting from malonyl-CoA and phenylpyruvate. A Claisen-type condensation catalyzed by a PLP-dependent amino acid-Cacyltransferase homolog, KtmB, is also involved. 
TOC Figure

Keywords
